Press Releases | BioSenic

Bone Therapeutics: Information on the total number of voting rights and shares (June 2019)

Read more about Bone Therapeutics: Information on the total number of voting rights and shares (June 2019)

Bone Therapeutics’ allogeneic cell therapy product ALLOB meets primary endpoints in Phase IIa study in patients undergoing a lumbar spinal fusion

Read more about Bone Therapeutics’ allogeneic cell therapy product ALLOB meets primary endpoints in Phase IIa study in patients undergoing a lumbar spinal fusion

Bone Therapeutics announces results of Annual General Meeting

Read more about Bone Therapeutics announces results of Annual General Meeting

Bone Therapeutics to participate in upcoming conferences

Read more about Bone Therapeutics to participate in upcoming conferences

Bone Therapeutics entre dans une nouvelle Phase de son développement Industriel

Read more about Bone Therapeutics entre dans une nouvelle Phase de son développement Industriel

Bone Therapeutics lève 9,5M €

Read more about Bone Therapeutics lève 9,5M €

Bone Therapeutics reçoit l'approbation des autorités et traite les premiers patients dans son étude clinique de phase III en ostéonécrose avec son produit PREOB®

Read more about Bone Therapeutics reçoit l'approbation des autorités et traite les premiers patients dans son étude clinique de phase III en ostéonécrose avec son produit PREOB®

Bone Therapeutics receives clearance for its pivotal phase III osteonecrosis trial with PREOB® in Europe and treats the first patients in the study

Read more about Bone Therapeutics receives clearance for its pivotal phase III osteonecrosis trial with PREOB® in Europe and treats the first patients in the study

Bone Therapeutics Raises €7.7 Million in Series D Fundraising

Read more about Bone Therapeutics Raises €7.7 Million in Series D Fundraising

Bone Therapeutics Invests in Cell Therapy Manufacturing Facility

Read more about Bone Therapeutics Invests in Cell Therapy Manufacturing Facility

Subscribe to Press Releases